The impending globalization of ADHD: Notes on the expansion and growth of a medicalized disorder

被引：120

作者：

Conrad, Peter ^{[1
]}

Bergey, Meredith R. ^{[1
]}

机构：

[1] Brandeis Univ, Dept Sociol, Waltham, MA 02454 USA

来源：

SOCIAL SCIENCE & MEDICINE | 2014年 / 122卷

关键词：

ADHD; Globalization; Medicalization; Diagnosis; ICD; DSM; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT-HYPERACTIVITY DISORDER; INTERNATIONAL CONSENSUS STATEMENT; ELECTRONIC SUPPORT GROUPS; PSYCHOTROPIC MEDICATIONS; CHILDHOOD HYPERACTIVITY; UNITED-STATES; ADULT ADHD; DSM-III; PREVALENCE;

D O I：

10.1016/j.socscimed.2014.10.019

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Attention Deficit Hyperactivity Disorder (ADHD) has been medicalized in the United States since the 1960s. Primarily used in North America until the 1990s, ADHD diagnosis and treatment have increasingly been applied internationally. After documenting the expansion of ADHD in a global context, this paper presents five brief international examples examining ADHD usage and expansion: the United Kingdom, Germany, France, Italy and Brazil. We then identify and describe several vehicles that facilitate the migration of the ADHD diagnosis: the transnational pharmaceutical industry; the influence of western psychiatry; moving from ICD to DSM diagnostic criteria; the role of the Internet including the related advent of easily accessible online screening checklists; and advocacy groups. Finally, we discuss what this globalization of a diagnosis reflects about the potential global medicalization of other conditions. (C) 2014 Elsevier Ltd. All rights reserved.

引用

页码：31 / 43

页数：13

共 145 条

[91]

Lohse M., 2009, Arzneiverordnungsreport 2009 S, P767

[92]

Malacrida Claudia., 2003, COLD COMFORT

[93]

Marchini L., 2000, OCCHIO CLIN PEDIAT, V4, P12

[94]

Marzocchi GM., 2000, Psicologia Clinica dello Sviluppo, V4, P43